Brain & Spine Institute
Can Polio Virus Help Treat Brain Tumors?
UConn Health is enrolling patients in a national trial testing a therapy derived from the polio virus paired with an established cancer medication to treat a type of aggressive brain tumor
2021 Top Doctors Named by Connecticut Magazine
See which 43 UConn Health physicians have been named 2021 Top Doctors by Connecticut Magazine. Plus, read more about four UConn Health doctors and their additional unique talents beyond their daily practice of medicine.
High-Profile Brain Tumor Therapy Trial Chooses UConn Health
An immunotherapy derived from the polio virus has shown improved survival rates in early-phase trials in patients with an aggressive type of brain tumor known as glioblastoma. UConn Health will be one of a select few sites in the U.S. for the second phase, which will pair it with the cancer immunotherapy pembrolizumab (Keytruda).
The Brain and Spine Institute at UConn Health
UConn Health has brought together our world-renowned experts from neurology, neurosurgery, spine surgery, non-operative spine care, and radiology to offer comprehensive, personalized care at The Brain and Spine Institute at UConn Health.
UConn Health Minute: Understanding Brain Tumors
Cancerous or malignant, brain tumors tend to grow quickly and disrupt the way your body works, and this can be life-threatening. As UConn Health neuro-oncologist Dr. Kevin Becker explains, interdisciplinary collaboration and a patient-centered approach to care is key in identifying brain and spine tumors early and providing the most advanced treatments available.
A United Fight Against Brain and Spinal Tumors
UConn Health, in collaboration with The Jackson Laboratory for Genomic Medicine, establishes a brain and spinal tumor board to enhance its unique position to provide precision treatment.